Literature DB >> 9699669

Maturation of cytotoxic T lymphocytes against a B7-transfected nonmetastatic tumor: a critical role for costimulation by B7 on both tumor and host antigen-presenting cells.

M Maric1, P Zheng, S Sarma, Y Guo, Y Liu.   

Abstract

It is generally believed that CTLs mature in lymphoid organs and then migrate into target tissues to execute their effector functions. This notion, however, is based on studies using antigens that are readily localized in the lymphoid tissue, such as viruses and allogeneic transplants. The site for maturation of CTLs for nonmetastatic tumors has not been determined. Because nonmetastatic tumor cells are not localized in lymphoid tissues, it is questionable whether such tumors are efficient inducers of antitumor CTLs. Here, we report that a nonmetastatic B7+ plasmacytoma induces strong effector CTL response. Thus, it is possible to induce CTLs with strong ex vivo CTL activity in the absence of tumor metastasis. In addition, a detailed kinetic analysis of CD8 T cell recruitment and maturation of CTL activity suggests that antitumor CTLs mature within the tumor rather than in the lymphoid tissues. Interestingly, despite B7-1 expression on tumor cells, induction of effector CTLs also requires costimulation by B7 on host antigen-presenting cells. These findings have important implications for tumor gene therapy and for understanding the mechanism of CTL induction in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699669

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  Genetic engineering of T cells for adoptive immunotherapy.

Authors:  Angel Varela-Rohena; Carmine Carpenito; Elena E Perez; Max Richardson; Richard V Parry; Michael Milone; John Scholler; Xueli Hao; Angela Mexas; Richard G Carroll; Carl H June; James L Riley
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 2.  Treatment of lymphoma with adoptively transferred T cells.

Authors:  Brian G Till; Oliver W Press
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

3.  B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo.

Authors:  X Liu; X F Bai; J Wen; J X Gao; J Liu; P Lu; Y Wang; P Zheng; Y Liu
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

4.  Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo.

Authors:  S Sarma; Y Guo; Y Guilloux; C Lee; X F Bai; Y Liu
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.